Literature DB >> 23293710

(68)Ga-DotaTATE PET-CT followed by Peptide Receptor Radiotherapy in combination with capecitabine in two patients with Merkel Cell Carcinoma.

Matthias C Schmidt1, Klara Uhrhan, Birgid Markiefka, Laura Hasselbring, Max Schlaak, Birgit Cremer, Sabine Kunze, Richard P Baum, Markus Dietlein.   

Abstract

Herein, we report about two Caucasian patients with the histopathological diagnosis of Merkel cell carcinoma suffering from extensive lymph node metastases. The extent of the disease was diagnosed by Ga-68-DotaTATE-PET-CT. Both patients had rapid disease progression, one of them despite a three months course of sunitinibe followed by four chemotherapy cycles of cisplatin and etoposide. Both patients were sent for peptide receptor radiotherapy with 90Y-DotaTATE or 177Lu-DotaTATE in combination with capecitabine. Additional external beam radiotherapy of the cervical and inguinal lymph nodes was given to the patient with progressive disease despite chemotherapy. Temporary partial response in both patients was achieved. Despite extensive therapeutic efforts, fatal outcome could not be prevented 10 and 14 months after first clinical symptoms.

Entities:  

Keywords:  177Lu-DotaTATE; 68Ga-DotaTATE; 90Y-DotaTATE; Merkel cell carcinoma (MCC); PET-CT; Peptide Receptor Radiotherapy (PRRT); Theranostic

Year:  2012        PMID: 23293710      PMCID: PMC3526339     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  15 in total

1.  Somatostatin analogue scintigraphy. A simple and sensitive method for the in vivo visualization of Merkel cell tumors and their metastases.

Authors:  D J Kwekkeboom; A M Hoff; S W Lamberts; H Y Oei; E P Krenning
Journal:  Arch Dermatol       Date:  1992-06

2.  68Ga-DOTATATE-PET/CT positive metastatic lymph node in a 69-year-old woman with Merkel cell carcinoma.

Authors:  Christina Schneider; Max Schlaak; Marc Bludau; Birgid Markiefka; Matthias C Schmidt
Journal:  Clin Nucl Med       Date:  2012-11       Impact factor: 7.794

3.  Trabecular carcinoma of the skin.

Authors:  C Toker
Journal:  Arch Dermatol       Date:  1972-01

4.  Interest of (18)F-FDG PET-CT scanning for staging and management of merkel cell carcinoma: a retrospective study of 15 patients.

Authors:  G Maury; O Dereure; A Du-Thanh; D Mariano-Goulart; B Guillot
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-03-02       Impact factor: 6.166

Review 5.  Merkel cell tumour: clinical behaviour and treatment.

Authors:  J H Shaw; E Rumball
Journal:  Br J Surg       Date:  1991-02       Impact factor: 6.939

6.  Merkel cell carcinoma: CT findings in 12 patients.

Authors:  M J Gollub; D R Gruen; D D Dershaw
Journal:  AJR Am J Roentgenol       Date:  1996-09       Impact factor: 3.959

7.  The impact of (18)F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia.

Authors:  Rebecca Concannon; George S Larcos; Michael Veness
Journal:  J Am Acad Dermatol       Date:  2010-01       Impact factor: 11.527

8.  New immunocytochemical observations with diagnostic significance in cutaneous neuroendocrine carcinoma.

Authors:  H Hoefler; H Kerl; H J Rauch; H Denk
Journal:  Am J Dermatopathol       Date:  1984-12       Impact factor: 1.533

9.  Trabecular carcinoma of the skin: an ultrastructural study.

Authors:  C K Tang; C Toker
Journal:  Cancer       Date:  1978-11       Impact factor: 6.860

10.  Epidermal progenitors give rise to Merkel cells during embryonic development and adult homeostasis.

Authors:  Alexandra Van Keymeulen; Guilhem Mascre; Khalil Kass Youseff; Itamar Harel; Cindy Michaux; Natalie De Geest; Caroline Szpalski; Younes Achouri; Wilhelm Bloch; Bassem A Hassan; Cédric Blanpain
Journal:  J Cell Biol       Date:  2009-09-28       Impact factor: 10.539

View more
  6 in total

1.  Peptide receptor radionuclide therapy of treatment-refractory metastatic thyroid cancer using (90)Yttrium and (177)Lutetium labeled somatostatin analogs: toxicity, response and survival analysis.

Authors:  Hendra Budiawan; Ali Salavati; Harshad R Kulkarni; Richard P Baum
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-12-15

2.  Nuclear medicine techniques in Merkel cell carcinoma: A case report and review of the literature.

Authors:  Nikolaos Kritikos; Dimitrios Priftakis; Stavros Stavrinides; Stefanos Kleanthous; Eleni Sarafianou
Journal:  Oncol Lett       Date:  2015-06-16       Impact factor: 2.967

3.  Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging.

Authors:  Kristina Buder; Constantin Lapa; Michael C Kreissl; Andreas Schirbel; Ken Herrmann; Alexander Schnack; Eva-Bettina Bröcker; Matthias Goebeler; Andreas K Buck; Jürgen C Becker
Journal:  BMC Cancer       Date:  2014-04-17       Impact factor: 4.430

4.  Molecular imaging and therapy of merkel cell carcinoma.

Authors:  Volkan Beylergil; Jorge A Carrasquillo
Journal:  Cancers (Basel)       Date:  2014-04-29       Impact factor: 6.639

5.  PET and PET/CT with 68gallium-labeled somatostatin analogues in Non GEP-NETs Tumors.

Authors:  Martina Sollini; Paola Anna Erba; Alessandro Fraternali; Massimiliano Casali; Maria Liberata Di Paolo; Armando Froio; Andrea Frasoldati; Annibale Versari
Journal:  ScientificWorldJournal       Date:  2014-02-13

6.  18F-FDG and 68Ga-somatostatin analogs PET/CT in patients with Merkel cell carcinoma: a comparison study.

Authors:  Silvia Taralli; Martina Sollini; Michele Milella; Germano Perotti; Angelina Filice; Massimo Menga; Annibale Versari; Vittoria Rufini
Journal:  EJNMMI Res       Date:  2018-07-21       Impact factor: 3.138

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.